Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCREDIBLE
NCT07699627Phase 2Not yet recruiting
- Sponsor
- Centre Hospitalier Le Mans
- Start
- Sep 2026
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Phase 2, randomised trial of Ketosteril in end stage renal disease (ESRD) (2 arms), sponsored by Centre Hospitalier Le Mans. Primary endpoint: Duration of incremental haemodialysis period at 24 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Ketosteril
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT07699627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07699627.